期刊文献+

低分子肝素联合西地那非治疗肺切除术后肺动脉高压的疗效分析 被引量:1

Effects analysis of low molecular weight heparin combined with sildenafil in the treatment of pulmonary hypertension after lung resection
下载PDF
导出
摘要 目的探讨低分子肝素联合西地那非治疗肺切除术后肺动脉高压的临床疗效。方法将13例肺切除术后肺动脉高压患者随机分为三组,使用西地那非(A组),使用低分子肝素(B组),联合应用上述两种方法(C组),三组患者在干预前、干预后第3天和第7天均再次测定肺动脉压力。结果应用西地那非组和低分子肝素组肺动脉压力第3天和第7天均有下降,结果有统计学意义(P<0.05)。而联合干预组肺动脉压力下降更明显,结果有统计学意义(P<0.05)。结论早期联合应用低分子肝素和西地那非对降低肺动脉压力有协同作用。 Objective To analyze the curative effects of low molecular weight heparin combined with sildenafil in the treatment of pulmonary hypertension after lung resection. Methods The patients were randomly divided imo three groups : the use of Sildenalil ( Group A ), the use of Low molecular weight heparin ( Group B ), the combination of these two methods ( Group C ), three groups of patients after intervention, interventiun before the third day and seven days are once again the determination of pulmonary artery pressure. Results Appficafion of Sildenafil puhnonary arterial pressure groups ,and Low molecular weight heparin group third and seventh days were dropped, the result was statistically significant ( P〈0.05 ).Combined pulmonary arterial pressure drop in the intervention group more obvious, the result was statistically significant ( P〈0.05 ). Conclusions Early combination of Low molecular weight heparin and Sildenafil on a collaborative role in reducing pulmonary arterial pressure.
出处 《中国处方药》 2013年第6期32-33,共2页 Journal of China Prescription Drug
关键词 肺切除 肺动脉高压 低分子肝素 西地那非 Lung resection Puhnonary hypertension Low molecular weight hepafin Sidenafil
  • 相关文献

参考文献4

  • 1Humbert M, Khahaev N, Bousquet J, et al. Pulmonary hypertension: from an orphan disease to a public health problem. Chest,2007,132(2):365-367.
  • 2Toshner M, Yoswinckel R, Southwood M, et al. Evidence for dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am J Respir Crit Care Med, 2009,180(8):780-787.
  • 3无.肺动脉高压筛查诊断与治疗专家共识[J].中华心血管病杂志,2007,35(11):979-987. 被引量:272
  • 4Minai OA, Arroliga AC. Long-term results after addition of sildenafil in idiopathic PAH patients on bosentan. South Med J, 2006, 99(8):880-883.

二级参考文献31

  • 1荆志成,徐希奇.肺动脉高压现代分类和诊断策略[J].中华心血管病杂志,2004,32(12):1160-1162. 被引量:40
  • 2荆志成.六分钟步行距离试验的临床应用[J].中华心血管病杂志,2006,34(4):381-384. 被引量:98
  • 3Proceeding of 3rd World Symposium on Pulmonary Arterial Hypertension. Venice, Italy, June 23-25, 2003. J Am Coll Cardiol, 2004,43(2 Suppl S) : 1S-90S.
  • 4Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest, 2004, 126( Suppl 1 ) : 1 S-92S.
  • 5Galie N, Torbicki A, Barst A, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J, 2004,25 ( 24 ) : 2243-2278.
  • 6Barst RJ, McGoon M, Torbicki A,et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol, 2004,43( 12 Suppl S) :40S-47S.
  • 7Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol, 2004,43 (12) :5S-12S.
  • 8Pietra GG, Capron F, Stewart S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol, 2004,43(12 Suppl S) :25S-32S.
  • 9McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension : ACCP evidence-based clinical practice guidelines. Chest, 2004,126 (1 Suppl): 14S-34S.
  • 10Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med, 2006,173 (9) :1023-1030.

共引文献271

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部